Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;28(2):107-14.
doi: 10.1007/s10875-007-9139-2. Epub 2007 Oct 16.

Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer

Affiliations

Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer

Stefanie Stanzer et al. J Clin Immunol. 2008 Mar.

Abstract

Regulatory T cells may be crucial in the development of T cell tolerance to malignancies and contribute to immune dysfunctions. We investigated the percentage, activity, and onset of apoptosis of T cell subpopulations by multicolor flow cytometry in metastatic epithelial cancer patients compared to normal controls. Furthermore, a possible relationship between the presence of circulating tumor cells detected by immunocytochemistry and immune cell abnormalities was evaluated. Our study demonstrated a significantly elevated proportion of regulatory T cells in cancer patients (p < 0.001). In contrast to all other T cell subpopulations, regulatory T cells showed comparable Annexin V-binding characteristics in patients and normal controls. No relationship between the detection of circulating tumor cells and immune dysfunction was observed. These results indicate that cancer patients have a higher number of regulatory T cells with resistance to apoptotic stimuli partly responsible for immune dysfunctions as often observed in cancer patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2004 Aug 19;351(8):781-91 - PubMed
    1. J Clin Invest. 2004 Aug;114(4):468-71 - PubMed
    1. Cancer Immunol Immunother. 2006 Sep;55(9):1064-71 - PubMed
    1. J Immunol. 1999 Nov 15;163(10):5211-8 - PubMed
    1. Clin Cancer Res. 2005 Feb 1;11(3):1010-20 - PubMed

Publication types

MeSH terms

LinkOut - more resources